We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

4 hedge funds and large institutions have $0 invested in Insys Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding

Funds holding: 16 → 4 (-12)

92% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 13

100% less capital invested

Capital invested by funds: $52K → $0 (-$52K)

Holders
4
Holders Change
-12
Holders Change %
-75%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
California Public Employees Retirement System
California Public Employees Retirement System
California
-$23K
2
KBC Group
KBC Group
Belgium
-$16K
3
Barclays
Barclays
United Kingdom
-$10K
4
WS
Wedbush Securities
California
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
– -$23K -75,500 Closed
KBC Group
2
KBC Group
Belgium
– -$16K -52,606 Closed
Barclays
3
Barclays
United Kingdom
– -$10K -33,172 Closed
WS
4
Wedbush Securities
California
– -$3K -10,500 Closed

INSY Hedge Fund Activity: Q3 2019 in Review

4 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q3 2019, worth a combined $0 — down 100% from $52K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of INSY and 1 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $23K sold.

  • 4 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q3 2019, down from 16 in Q2 2019.
  • Funds reported $0 of Insys Therapeutics, Inc. stock for Q3 2019, down 100% quarter-over-quarter.
  • 1 fund opened new Insys Therapeutics, Inc. positions in Q3 2019 and 13 closed out, a net change of -12 holders.
  • The largest Insys Therapeutics, Inc. seller in Q3 2019 was California Public Employees Retirement System, an estimated $23K sold.

Based on aggregated 13F filings for Q3 2019.